Assessing value of pathogen-specific vaccines against gastroenteritis Clinical study 22 February 2020 Pages: 3 - 3
C. difficile vaccine cost effective for prevention of nosocomial CDI Clinical study 22 February 2020 Pages: 4 - 4
Cetuximab + chemotherapy in metastatic CRC: not cost effective in China Clinical study 22 February 2020 Pages: 5 - 5
Chronic hepatitis B: large economic burden with standard treatment Clinical study 22 February 2020 Pages: 6 - 6
Cost implications of different IV iron formulations in an iron infusion clinic Clinical study 22 February 2020 Pages: 7 - 7
Costs lowest when bDMARD sequences start with etanercept biosimilar Clinical study 22 February 2020 Pages: 8 - 8
Dalbavancin in acute bacterial skin infections saves costs Clinical study 22 February 2020 Pages: 9 - 9
Dexrazoxane cost effective in preventing anthracycline cardiotoxicity Clinical study 22 February 2020 Pages: 10 - 10
Fecal microbiota transplant cost effective for recurrent CDI in IBD Clinical study 22 February 2020 Pages: 11 - 11
Higher insulin prices increase OOP costs despite reduced coverage gap Clinical study 22 February 2020 Pages: 12 - 12
Idiopathic pulmonary fibrosis: cost of hospital care substantial in the US Clinical study 22 February 2020 Pages: 13 - 13
Increase in costs of antiretroviral therapy in USA outpacing inflation Clinical study 22 February 2020 Pages: 14 - 14
Lifestyle interventions prevent adverse pregnancy outcomes at low cost Clinical study 22 February 2020 Pages: 15 - 15
Long-term costs of stroke care predicted by modified Rankin Scale score Clinical study 22 February 2020 Pages: 16 - 16
Medicaid expansions under Affordable Care Act reduce OOP spending Unknown 22 February 2020 Pages: 17 - 17
Naloxone cost effective in reducing deaths from opioid overdose Clinical study 22 February 2020 Pages: 19 - 19
Natalizumab preferred option for relapsing MS in Colombia Clinical study 22 February 2020 Pages: 20 - 20
Ocriplasmin cost effective in symptomatic vitreomacular adhesion Clinical study 22 February 2020 Pages: 21 - 21
Once-weekly semaglutide good value for money in T2DM in the UK Clinical study 22 February 2020 Pages: 22 - 22
Oral anticoagulants cost effective for thrombosis prevention in cancer Clinical study 22 February 2020 Pages: 23 - 23
Out-of-network bills for surgery at in-network facilities Clinical study 22 February 2020 Pages: 24 - 24
Poor glycaemic control major driver of healthcare costs in T2DM Clinical study 22 February 2020 Pages: 26 - 26
Primary care visits declining in commercially insured patients in USA Clinical study 22 February 2020 Pages: 27 - 27
Psychotherapy cost effective for HIV-related depression Clinical study 22 February 2020 Pages: 28 - 28
Quality improvement intervention for stroke care cost effective in China Clinical study 22 February 2020 Pages: 29 - 29
Recommendations alone may not reduce low-value screening Clinical study 22 February 2020 Pages: 30 - 30
Reinvestment of savings from lower-cost ARVs could avert HIV infections Clinical study 22 February 2020 Pages: 31 - 31
Screening for congenital adrenal hyperplasia cost effective in Canada Clinical study 22 February 2020 Pages: 32 - 32
Screening program for gastric cancer cost effective in South Korea Clinical study 22 February 2020 Pages: 33 - 33
Self-management of BP after stroke "unlikely to be cost effective" Clinical study 22 February 2020 Pages: 34 - 34
Voretigene neparvovec good value in inherited retinal dystrophies Clinical study 22 February 2020 Pages: 35 - 35